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Proteolytic enzymes are implicated in multiple physiological and pathological processes. The availability of the sequence of the chimpanzee
genome has allowed us to determine that the chimpanzee degradome—the repertoire of protease genes from this organism—is composed of at
least 559 protease and protease-like genes and is virtually identical to that of human, containing 561 genes. Despite the high degree of
conservation between both genomes, we have identified important differences that vary from deletion of whole genes to small insertion/deletion
events or single nucleotide changes that lead to the specific gene inactivation in one species, mostly affecting immune system genes. For example,
the genes encoding PRSS33/EOS, a macrophage serine protease conserved in most mammals, and GGTLA1 are absent in chimpanzee, while the
gene for metalloprotease MMP23A, located in chromosome 1p36, has been specifically duplicated in the human genome together with its
neighbor gene CDC2L1. Other differences arise from single nucleotide changes in protease genes, such as NAPSB and CASP12, resulting in the
presence of functional genes in chimpanzee and pseudogenes in human. Finally, we have confirmed that the Trypanosoma lytic factor HPR is
inactive in chimpanzee, likely contributing to the susceptibility of chimpanzees to T. brucei infection. This study provides the first analysis of the
chimpanzee degradome and might contribute to the understanding of the molecular bases underlying variations in host defense mechanisms
between human and chimpanzee.
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constitutes a fundamental advance toward understanding the
genetic basis of physiological differences between species
and will increase our knowledge of molecular aspects of
human diseases [1,2]. In this regard, the availability of the
chimpanzee (Pan troglodytes) genome sequence [3], which is
about 99% identical to that of the human genome, represents
an excellent opportunity to identify genetic changes that
might be responsible for some of the differences between
humans and chimpanzees [4]. The study of specific gene
families has proven very useful to facilitate the analysis of
this large amount of information and can contribute to the
understanding of global mechanisms implicated in the0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2005.07.009
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E-mail address: xspuente@uniovi.es (X.S. Puente).evolution of human and other mammalian organisms [5–
11]. Proteolytic enzymes are an excellent model for this kind
of analysis, because they constitute a very diverse group of
proteins representing more than 1.7% of all human genes. In
addition, there is a considerable amount of knowledge of the
structure and function of a significant number of proteases
(http://www.merops.ac.uk), as well as a growing understand-
ing of their relevance in numerous biological and pathological
processes [6,12]. This increasing complexity of proteolytic
systems has prompted us to introduce novel concepts and
experimental approaches into the global study of proteases
[12], including the concept of the degradome to define
the complete repertoire of protease genes present in one
organism.
A characteristic of proteolytic enzymes is their participa-
tion in essential biological processes such as cell cycle
progression, fertilization and development, migration and
neuritogenesis, tissue remodeling, apoptosis, and host de-5) 638 – 647
www.el
X.S. Puente et al. / Genomics 86 (2005) 638–647 639fense. The importance of proteolysis is further reflected by
the existence of more than 60 human hereditary diseases
due to mutations in protease genes [6] (http://www.uniovi.es/
degradome). In addition, alterations in the spatiotemporal
patterns of expression of proteases are associated with
numerous human pathologies, including cardiovascular dis-
eases, neurodegenerative diseases, rheumatoid arthritis, or
cancer [13]. However, despite the existence of numerous
expression studies of proteases in normal and pathological
conditions, little is known about the biological function of
many of these protease genes. In this regard, comparison
of human and chimpanzee degradomes can provide new
insights into the physiological and pathological relevance
of proteolytic enzymes and contribute to identifying in-
dividual genes or general processes that might have been
important for the evolution of these closely related
organisms.
In this work, we report the analysis of the complete set
of protease and protease-like genes in the chimpanzee
genome and its comparison to the human degradome. We
show that the chimpanzee degradome is composed of 559
protease and protease-like genes with more than 99.1%
identities with their human orthologs. We also describe the
identification and detailed analysis of several protease genes
that are different between human and chimpanzee and that
might be responsible for some of the physiological
differences between both species. On the basis of this
analysis, we conclude that most protease-gene differences
between both organisms are found in immune system genes,
highlighting the importance of analyzing a limited set of
genes to identify specific processes that might have been
altered as a result of evolution.Fig. 1. PRSS33 is absent from the chimpanzee genome. (A) Southern blot analysis
Chimpanzee BAC CH251-545K10, corresponding to the syntenic region of huma
PRSS27, PRSS33, and TESSP1 genes. The organization of this region in the human
E (EcoRI).Results
Comparison between human and chimpanzee protease genes
The chimpanzee degradome was identified and character-
ized by screening the chimpanzee genome with the complete
set of human protease genes as described under Materials and
methods. By following this strategy, we have concluded that
the chimpanzee degradome is virtually identical to that of
human, being composed of at least 559 protease genes
grouped in 68 different families (Fig. 1 and Supplemental
Table 1). The genome coverage for this set of genes is very
high (95.6% at the nucleotide level), similar to the draft
genome average [3]. In this sense, it cannot be ruled out that
other protease-coding genes could be present in unfinished
regions of the chimpanzee genome, although this possibility
is very unlikely due to the high coverage of the chimpanzee
genome and the fact that most gaps are smaller than the
average size of a protease gene [3]. Despite the high coverage
of the chimpanzee genome, we observed the presence of
frameshifts in coding sequences in at least 30 genes (5.3%),
thereby making it difficult to distinguish pseudogenized genes
from sequencing errors. As most of these putative frame-
shifted chimpanzee genes are functional in mouse or rat, we
resequenced those genes in which sequence problems were
located within regions of high-quality nucleotide sequence in
both ARACHNE and PCAP chimpanzee assemblies. This
analysis revealed that all observed frameshifts were due to
sequence problems in the assemblies (Supplemental Table 1).
Finally, and similar to the situation with available assemblies
for other genomes, the chimpanzee assemblies exhibit
problems in regions where tandem duplication of genes hasof genomic DNA from the indicated species with a human PRSS33 probe. (B)
n chromosome 16p13, was analyzed by Southern blot with probes for human
genome is shown below. Restriction enzymes are designated by B (BamHI) and
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assembly process. Nevertheless, and despite these limitations,
we have completed and evaluated data on 6760 chimpanzee
exons, and only 419 putative exons were not identified in the
sequence.
This analysis allowed us to conclude that there are 557
protease orthologous genes between human and chimpanzee,
showing an average of 99.06 and 99.11% identities at the
amino acid and nucleotide level (median 99.31 and 99.22%),
respectively, compared to the genome average of 98.77% [3].
Interestingly, there are at least 75 protease genes (13.5%) that
code for proteins completely identical to their human counter-
parts (Supplemental Table 1). This group of highly conserved
genes includes several housekeeping protease genes, such as
those encoding the different components of the proteasome, but
there are also numerous genes highly expressed in the nervous
system and implicated in neurological disorders, as is the
case of BACE1, PSEN1, UCHL1, or IMMP2L [14–17]. This
observation emphasizes the idea that most differences between
both species in this regard are not present in the coding
sequences but in regulatory elements, as previously shown for
genes expressed in the CNS [18,19]. In addition, our analysis
also revealed a number of chimpanzee protease genes that
differ significantly (by more than 2 standard deviations) from
their human orthologs, with identities at the protein level below
97% (Table 1). In all cases the amino acid substitutions were
located within the protease domain, suggesting that they might
influence the functional activity of the protease or its substrate
specificity. The observation that for some of these genes the
ratio of nonsynonymous (Ka) to synonymous (Ks) substitutions
was greater than 1 indicates that these genes have been
subjected to positive selection during the evolution. This group
contains many protease genes implicated in immunological
processes, including proteases from neutrophilic granules as
PRTN3, the natural killer granzymes GZMH and GZMM, mastTable 1
Differential and divergent protease genes between human and chimpanzee
Protease Gene Human locus Status/identity (
Caspase 12 CASP12 11q22 Pseudogene in h
EOS serine protease PRSS33 16p13 Absent in chimp
g-Glutamyltransferase-like A1 GGTLA1 22q11 Absent in chimp
Haptoglobin primate HPP – Absent in huma
Haptoglobin-related protein HPR 16q22 Pseudogene in c
Matrix metalloprotease 23A MMP23A 1p36 Absent in chimp
Napsin B NAPSB 19q13 Pseudogene in h
Pancreatic endopeptidase E (A) ELA3A 1p36 94.44
Proteinase 3 PRTN3 19p13 94.53
Plasma-kallikrein-like 1 KLKBL1 4q35 95.01
g-Glutamyltransferase-like 4 GGTL4 22q11 95.11
Tryptase a/tryptase h1 TPS1/TPSB1 16p13 95.27
Granzyme H GZMH 14q11 95.53
Tryptase h2 TPSB2 16p13 96.00
Caspase-5 CASP5 11q22 96.17
Complement factor D DF 19p13 96.44
Cathepsin G CTSG 14q11 96.86
Granzyme M GZMM 19p13 96.86
Plasma-kallikrein-like 2 KLKBL2 8p23 96.88
The status for differential genes is indicated, while for divergent genes the percentcell granule proteases as TPS1 or TPSB2, or the complement
factor D. Other genes showing a high degree of divergence
include the pancreatic elastase A (ELA3A) or the apoptosis-
related protease CASP5. These data are in agreement with
previous studies showing major differences in host defense
proteases between human and rodents [6,20] and suggest that
host defense has been one of the main driving forces in the
evolution of chimpanzee and human proteases.
We next examined the human and chimpanzee genomes for
the presence of specific gene duplications, as recent studies
suggest that at least one protease gene (USP10) has been
duplicated in the human genome compared to chimpanzee [21].
This analysis led us to find a protease gene, MMP23, encoding
a matrix metalloproteinase predominantly expressed in repro-
ductive tissues [22,23] and duplicated in the human lineage
(MMP23A and MMP23B). By contrast, we did not find
evidence of USP10 duplication in the human lineage.
Interestingly, we found that the human genome contains two
processed USP10 pseudogenes on chromosomes 14 and 22,
with numerous frameshifts that disrupt the reading frame and
result in premature stop codons. However, the chimpanzee
genome contains only one copy of the MMP23 gene and does
not contain USP10 pseudogenes and shows only a functional
USP10 gene at chromosome PTR18 syntenic to the human
USP10 gene located at 16q24. These findings could contribute
to explaining the differences observed in this regard when
comparative genomic hybridization is used to identify dupli-
cated genes.
Finally, the detailed comparative analysis of human and
chimpanzee degradomes led us to identify two additional
human genes—PRSS33 and GGTLA1—for which we could
not find an ortholog in the chimpanzee genome. Likewise, we
found three chimpanzee protease genes—NAPSB, CASP12,
and HPP—that are inactive or absent in human, as well as one
human gene—HPR—that has been specifically inactivated in%) Ka/Ks ratio Function
uman – Host defense, Alzheimer disease
– Host defense (?)
– Host defense(?)
n – Unknown
himp – Putative Trypanosoma lytic factor, host defense
– Unknown, expressed in lymphoid tissues
uman – Unknown, expressed in lymphoid tissues
0.3851 Digestion and cholesterol metabolism
1.0598 Neutrophilic granules protein, host defense
0.8885 Unknown
0.5575 Unknown
0.3237 Mast cell granules protein, host defense
2.8784 Neutrophilic granules protein, host defense
0.2665 Mast cell granules protein, host defense
1.7679 Processing of proinflammatory cytokines, host defense
0.8051 Complement factor D, host defense
0.4663 Neutrophilic granules protein, host defense
0.2507 Neutrophilic granules protein, host defense
1.3827 Unknown
age of identity at the protein level is shown.
Fig. 2. MMP23 and CDC2L genes are specifically duplicated in the human
genome. (A) Southern blot analysis of human (H) and chimpanzee (C) genomic
DNA digested with either NcoI or SphI, using a probe for human MMP23. (B)
Southern blot hybridization of human and chimpanzee DNA with a probe for
human CDC2L. Band identities are indicated by arrowheads.
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explaining some of the physiological differences between
human and chimpanzee, we performed a detailed analysis of
all of them in the chimpanzee genome.
Analysis of protease genes absent from the chimpanzee genome
Analysis of the chimpanzee degradome revealed that the
gene encoding the serine protease EOS was absent from the
chimpanzee genome. This gene has been conserved throughout
evolution, being present in human, mouse, rat, dog, cow, and
opossum genomes [20,24] (and data not shown). As this gene
is located in tandem with other serine protease genes in human
chromosome 16p13, its absence in the chimpanzee genome
could be the result of a sequence being artifactually collapsed
during the assembly process. To clarify this question, we
performed Southern blot analysis with genomic DNA from
different mammalian species using as a probe a 409-bp
fragment corresponding to human PRSS33. We detected a
hybridization band of the expected molecular weight in human,
mouse, and dog DNA (Fig. 1A), while no band was observed
in chimpanzee DNA, suggesting that PRSS33 is absent from
this primate. To investigate this finding further, we analyzed
two chimpanzee BAC clones spanning this region (CH251-
545K10 and CH251-350O2) for the presence of PRSS33 and
the immediately upstream and downstream genes in the human
genome—PRSS27/MPN and the pseudogene TESSP1, respec-
tively (Fig. 1B). As can be seen in Fig. 1B, PRSS27 and
TESSP1 were present in BAC CH251-545K10, while PRSS33
could not be detected in the same BAC nor in other BACs from
the same region (CH251-350O2, RP43-59F8, RP43-40A16)
(data not shown).
On the other hand, analysis of the chimpanzee genome
revealed the presence of a single gene for the matrix
metalloprotease MMP23, while the human genome contains
two closely related genes (99.9% identity at the nucleotide
level) encoding MMP23A and MMP23B and located in a
recently duplicated region of chromosome 1p36 [23]. A
detailed analysis of these genes revealed that chimpanzee
MMP23 was more closely related to human MMP23B,
suggesting the absence of MMP23A in chimpanzee. However,
the high sequence identity between both genes could result in
their artifactual collapse in the chimpanzee genome assembly,
as still is the case in the more recent human genome assembly
(NCBI build 35, May 2004). To investigate the absence of
MMP23A from the chimpanzee genome, we performed
Southern blot analysis using genomic DNA from human and
chimpanzee, BAC clones CH251-252K11, CH251-541E6, and
CH251-696F3 corresponding to this region, and PCR ampli-
fication followed by direct sequencing of theMMP23 gene. We
also investigated the presence of one or two copies of the
neighbor gene CDC2L, which is also duplicated in the same
region of the human genome resulting in two almost identical
genes, CDC2L1 and CDC2L2 [23]. This analysis revealed that
the chimpanzee genome appears to contain a single gene for
both MMP23 and CDC2L, as we detected a single hybridiza-
tion band corresponding to both genes in chimpanzee, whiletwo bands were clearly present in human (Figs. 2A and 2B). By
PCR amplification and direct sequencing of MMP23 and
CDC2L genes, we also confirmed that the chimpanzee contains
a single copy for both genes, which likely correspond to
MMP23B and CDC2L1. These data support the idea that this
region has been specifically duplicated in the human lineage
and might represent a region prone to genetic instability, as
demonstrated by the observation of frequent translocations and
deletions involving this region in different human tumors
[23,25,26].
The last identified protease gene absent from the chimpan-
zee genome is GGTLA1, encoding a threonine protease of the
g-glutamyltranspeptidase family. This gene is located in human
chromosome 22q11, a region that has undergone numerous
intrachromosomal duplications leading to the generation of
four closely related genes encoding g-glutamyltranspeptidases
and several pseudogenes [27]. The chimpanzee genome also
contains several copies of this group of genes, as well as some
pseudogenes, reflecting the dynamic nature of this region
(Supplemental Table 1 and data not shown). The high sequence
identity between the different human and chimpanzee genes
and the variable number of pseudogenes in both species greatly
hamper the analysis of this region. Moreover, this gene is
located within the immunoglobulin E chain C locus, a region of
genomic instability that might be polymorphic between
different individuals [28] and might contribute to explaining
its absence in chimpanzee.
Analysis of differential pseudogenization in protease genes
from human and chimpanzee
Because a common mechanism in the evolution of human
proteases has been the pseudogenization of several reproduc-
tive and immune system genes that are active in other species
X.S. Puente et al. / Genomics 86 (2005) 638–647642[20,29], we next examined the status of these genes/pseudo-
genes in chimpanzee. Despite the above-mentioned limitations
in the analysis, we can conclude that all examined human
pseudogenes related to reproductive proteases are also inactive
in chimpanzee, although there are some cases (ADAM6,
PRSS29P) that have been pseudogenized by different mechan-
isms in human and chimpanzee (Supplemental Fig. 1). In the
case of immune system genes, we have found that the gene for
napsin B (NAPSB), which had been previously described as a
human pseudogene [30], appears to be functional in chimpan-
zee. This pseudogene is located in a duplicated region in
human chromosome 19q13 that contains the aspartic protease
gene NAPSA, as well as the related pseudogene NAPSB, which
lacks an in-frame stop codon and leads to the synthesis of a
nonfunctional protein [30]. However, after PCR amplification
and direct sequencing, we have verified that the corresponding
region in the chimpanzee genome contains an in-frame
stop codon at a position equivalent to that of human and
chimpanzee NAPSA (Fig. 3A), strongly suggesting that
chimpanzee NAPSB codes for a functional aspartic protease.
Finally, the observation that the human NAPSB pseudogene is
specifically expressed in lymphoid tissues [31] also suggests
that its active chimpanzee counterpart might contribute to some
of the functional differences between human and chimpanzee
immune systems [32–35].
Another interesting case is that of caspase-12 (CASP12),
which has acquired two different mutations in humans—a
frameshift mutation in exon 3 and a nonsense mutation in exon
4—while its mouse and rat orthologs are functional enzymes.
Therefore, CASP12 had been classified as a pseudogene in
humans [36]. However, it has been recently described that as
much as 20% of the South African and African American
population contains a polymorphism in which the stop codon
(TGA) in exon 4 is replaced by an Arg codon (CGA) [37]. This
polymorphism leads to the production in some humans of a
full-length caspase proenzyme by deletion of exon 3 through
alternative splicing [37]. Direct sequencing of this region inFig. 3. Napsin B and caspase-12 are functional proteases in chimpanzee. (A) Mult
napsins. Human napsin B (NAPSB) lacks an in-frame stop codon. The conceptu
organization of caspase-12 showing the premature stop codon in exon 4 present in
caspase-12 from different mammals shows the absence of a critical residue for prochimpanzee DNA samples from different geographical regions
has allowed us to confirm that chimpanzee CASP12 presents an
Arg codon (CGA) instead of the TGA codon present in most
humans, suggesting that in chimpanzees CASP12 is a
functional gene (Fig. 3B). Furthermore, it must be emphasized
that human caspase-12 does not contain a functional SHG box,
a crucial element for the enzymatic activity of caspases,
thereby indicating that even the full-length isoform of
caspase-12 found in some humans lacks protease activity
[36,37]. Interestingly, chimpanzee caspase-12 contains a
complete SHG box as well as all residues involved in catalysis
(Fig. 3B), suggesting that it is an active protease, similar to its
murine and rat counterparts.
Finally, we have confirmed in the chimpanzee genome the
previous experimental observation that a human serine
protease-like gene (haptoglobin-related protein, HPR) is a
pseudogene in chimpanzee [38]. HPR is a highly polymorphic
gene in human and exhibits multiple copies in the black
population. By contrast, the haptoglobin primate gene (HPP) is
present in chimpanzee and absent in human [39]. This HPR
gene has been identified as the Trypanosoma lytic factor and
could contribute to explaining the human resistance to the
disease caused by T. brucei in other species including
chimpanzee [40]. This finding prompted us to analyze other
genes for putative lytic factors and allowed us to conclude that
APOL1, another proposed lytic factor for T. brucei [41], is
absent in chimpanzee (see Supplemental Fig. 2).
Analysis of insertions, deletions, and disease variants in
chimpanzee proteases
The insertion or deletion of specific residues can influence
the activity or stability of a protein and constitutes a
mechanism underlying numerous human diseases [42]. The
analysis of human and chimpanzee degradomes allowed us to
identify 26 chimpanzee proteases that contain inserted or
deleted residues compared to the human sequence (Supple-iple amino acid alignment of the C-terminal region of human and chimpanzee
al translation of the 3VUTR region and poly(A) tail is shown. (B) Domain
more than 90% of the human population. Alignment of the SHG box region
teolysis in human caspase-12.
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affected just one or two residues, and in 42% of the cases it was
located in a highly repetitive region that could be unstable and
even polymorphic in humans. However, we found two genes,
ADAMTS20 andMMP9, which showed a significant number of
deleted amino acids compared to the human sequence. In the
case of ADAMTS20, a multidomain metalloprotease expressed
in testis and brain [43], we identified a deletion of exons 22 and
23 in a region that does not show gaps in the assembly. PCR
amplification and direct sequencing of this region allowed us to
confirm this deletion, which results in the production of a
mature protein lacking residues 1031 to 1125 (human
numbering) (Fig. 4A). Deletion of exons 22 and 23 results in
a truncated protein lacking two of the C-terminal thrombos-
pondin-1 repeats that are conserved in the human and mouse
sequences (Fig. 4A). In the case of MMP9, we observed the
deletion of eight residues (483 to 490, human numbering) in
the hinge region [13] (Fig. 4B). These results suggest that
insertion/deletion events in protease sequences could represent
an additional mechanism to generate diversity among proteo-
lytic enzymes from human and chimpanzee.
Finally, detailed analysis of the 64 genes mutated in human
hereditary diseases of proteolysis [6] has revealed that all of
them have a conserved ortholog in chimpanzee, including
caspase-10, mutated in a lymphoproliferative syndrome, and
there are no orthologs in mouse and rat. Nevertheless, there are
human disease variants in protease genes present in chimpan-
zee. This is the case with PRSS1, which encodes cationic
trypsinogen. A mutation, N29T, enhances intrapancreatic
trypsin activity and causes autosomal dominant hereditary
pancreatitis [44]. We have verified by PCR amplification and
sequence analysis the presence of Thr at position 29 in
chimpanzee PRSS1, thereby providing an additional example
of the usefulness of the chimpanzee genome sequence to
identify differences in genes associated with human diseases.Fig. 4. ADAMTS20 and MMP9 show deletions in chimpanzee. (A) Amino ac
ADAMTS20 showing the specific deletion of two TSP1-like repeats in chimpanzee
hinge region of MMP9 from different mammalian organisms shows that chimpanzDiscussion
In this work, we have performed a comparative analysis of
the chimpanzee and human degradomes, the complete set of
protease genes from these organisms. The chimpanzee degra-
dome contains 559 protease-coding genes, a number similar to
that of the human degradome (561 genes). Despite the high
sequence conservation between human and chimpanzee pro-
teases (99.1%), a number of protease genes implicated in
immunological functions show a higher degree of divergence.
Moreover, we have identified 7 differential protease genes
between human and chimpanzee, and most of them are
associated with the immune system. An interesting observation
in this regard is that the two proposed Trypanosoma lytic
factors of human serum, haptoglobin-related protein and apoL1
[40,41], are inactive or absent from the chimpanzee genome.
This difference might explain the absence of Trypanosoma
lytic factors in serum from chimpanzee and the susceptibility of
chimpanzees to the disease caused by T. brucei. This finding
highlights the utility of genome comparison to identify genes
responsible for the observed phenotypic differences between
closely related species. Additionally, we have identified other
genes associated with the immune system that are either absent
in one species, including PRSS33, CASP12, or NAPSB, or
highly divergent and subject to positive selection, including
proteases from neutrophilic granules such as PRTN3 or GZMH
or proteases implicated in the processing of proinflammatory
cytokines such as CASP5, which might contribute to differ-
ences in host defense between both organisms. These findings
support previous observations that indicate that host defense
has been a major driving force during evolution [20,32–35],
probably due to exposure to different pathogenic agents and/or
parasites. The identification of these differential protease genes
between human and chimpanzee represents an starting point to
explore the physiological consequences associated with theseid alignment and domain structure organization of human and chimpanzee
due to a deletion through exons 22 and 23. (B) Amino acid alignment of the
ee MMP9 has the shortest hinge region.
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fully the relevance of the findings described in this work. In
this sense, recent studies have provided increasing evidence of
the importance of the immune system in complex pathological
processes such as cancer susceptibility and progression [45–
47]. Therefore, it is tempting to speculate that differences in
protease genes implicated in immunological functions might
contribute to explain the reduced incidence of solid tumors in
chimpanzee [48,49].
During this protease gene comparative analysis, we also
confirmed and extended previous observations suggesting that
pseudogenization of specific genes has contributed to the
evolution of mammalian genomes [4]. Thus, ADAM6 and
ISP2, implicated in reproduction in mouse and rat, have been
inactivated in both human and chimpanzee genomes. However,
it is interesting to note that they have been inactivated by
different mechanisms, suggesting that the pseudogenization of
these genes occurred after the human–chimpanzee split. We
have also confirmed the presence in chimpanzee of genes
encoding important reproductive proteases that are absent in
mouse and rat. This is the case of prostate-specific antigen
(KLK3), which is involved in the proteolytic cleavage of
semenogelins (SEMG1 and SEMG2), the major structural
proteins in human semen. Interestingly, analysis from chim-
panzee assemblies has corroborated the recent finding of
marked differences between human and chimpanzee semeno-
gelins [50]. Thus, SEMG1 is extended at the C-terminal end,
originating a considerably longer protein than its human
counterpart. By contrast, SEMG2 is truncated due to the
presence of a premature stop codon. Therefore, despite the
absence of marked changes in reproductive proteases between
human and chimpanzee, differences in their targeted substrates
may be responsible for some of the changes in the reproductive
biology of both species.
Likewise, we have also identified two genes, coding for
napsin B and caspase-12, which appear to be functional in
chimpanzee, but have been inactivated by mutations in the
human genome. We still do not know the functional
significance of the presence of napsin B in chimpanzee, but
due to its putative expression in lymphoid tissues, it might
participate in host defense functions. The case of CASP12 is
also noteworthy because although it has long been considered
a human pseudogene due to the presence of two different
mutations [36], a recent study has demonstrated that as
much as 20% of the South African and African American
population may produce a complete protein [37]. Further-
more, the fact that the intact isoform of human caspase-12 has
changes in key residues suggests that humans have lost the
original function of this gene, while in chimpanzees it should
be a bona fide protease. This gene has been implicated in
immunological functions, as it is expressed in the immune
system, and individuals producing caspase-12 have an
increased risk of severe sepsis [37]. However, the presence
of an active caspase-12 protease in chimpanzee and rodents
could lead to the activation of inflammatory mediators and
result in differences in the inflammatory response between
humans and other species. Additionally, it has been shownthat caspase-12 mediates h-amyloid-induced apoptosis in
mice [51], raising the hypothesis that the inactivation of
human CASP12 might contribute to an increased risk to
develop Alzheimer disease.
The comparison between human and chimpanzee proteases
also allowed us to identify numerous insertion/deletion events
that can influence the activity of these enzymes. An interesting
finding is the specific deletion of two complete exons from
ADAMTS20 that results in the absence of two thrombospondin-
1 repeats conserved from rodents to humans. The functional
significance of this deletion is unclear, but it has been proposed
that thrombospondin repeats could be implicated in substrate
specificity or interaction with extracellular matrix proteins,
which could affect the activity of chimpanzee ADAMTS20.
Interestingly, this region has been shown to be important in the
activity of this protease, as inactivating mutations in murine
Adamts20 and in gon1, the Caenorhabditis elegans ortholog of
ADAMTS20, are localized to this C-terminal region [52,53].
The fact that ADAMTS20 is expressed at high levels in testis
[43] agrees with previous studies that show that genes
implicated in reproductive functions have been subjected to
numerous changes during evolution [20,50] and could contrib-
ute to explaining some of the differences in reproduction
between human and chimpanzee. Additionally, we found that
chimpanzee MMP9—a multifunctional protease with an
important role in the regulation of inflammatory processes
[47,54]—has eight residues deleted within the hinge region.
Similar to the case of ADAMTS20, the hinge region in MMPs
is believed to be important in substrate specificity by keeping
the metalloprotease domain at an appropriate distance from the
hemopexin domain [55]. Together, these results suggest
additional mechanisms by which genetic changes might
generate functional diversity in this group of enzymes by
affecting substrate specificity, proteolytic activity, or sensitivity
to specific inhibitors.
Finally, we have found two genes (PRSS33 and GGTLA1)
of putative immunological relevance that are absent from the
chimpanzee genome. The gene encoding the EOS serine
protease is expressed in macrophages and is present in all
sequenced mammalian genomes to date [20,24]. In human, this
gene is located at chromosome 16p13 in a region containing
four serine protease genes in tandem, as well as two
pseudogenes and multiple repetitive elements. This region
appears to be very unstable and has undergone an extensive
reorganization during evolution, as deduced from the different
numbers of genes contained in the equivalent region in rodents
and primates. It is likely that inversions have occurred more
than once during evolution and resulted in the elimination of
PRSS33 from the chimpanzee genome. Our preliminary studies
suggest that PRSS33 is present in gorilla, orangutan, and
mandrill (data not shown), which implies that somehow
PRSS33 was deleted after the split from the last human–
chimpanzee common ancestor. Likewise, the gene encoding
GGTLA1 appears to be absent in chimpanzee. This gene
encodes a member of the g-glutamyltranspeptidase family, a
group of enzymes that have been implicated in T-cell-mediated
immune responses [56].
X.S. Puente et al. / Genomics 86 (2005) 638–647 645In summary, this work provides the first overview of the
chimpanzee degradome and constitutes a first approach to
understanding the genetic basis underlying differences in
protease-mediated processes between human and chimpanzee.
We have analyzed more than 550 genes and showed that most
differences are found in protease genes implicated in immu-
nological functions. Human–chimpanzee differences in pro-
teolytic genes vary from deletion of whole genes to small
insertion/deletion events or to single nucleotide changes that
lead to gene inactivation in one species or the other.
Nevertheless, the small number of differences between human
and chimpanzee degradomes suggests that changes in regula-
tory elements or in protease inhibitors can also contribute to
differences in proteolysis between both organisms. Studies now
in progress aimed at analyzing these differential genes further
will help to define their precise contribution to the physiolog-
ical differences between human and chimpanzee.
Materials and methods
Bioinformatic analysis
The human degradome database has been previously described [6,20] and is
detailed in Supplemental Table 1. Due to the high percentage of identities
between human and chimpanzee genomes, human protease cDNA sequences
obtained from the RefSeq and GenBank databases were first curated to remove
sequencing errors that would result in artifactual differences between human
and chimpanzee proteases. During this procedure, we realized that about 60%
of the RefSeq deposited sequences contained nucleotide changes or frameshifts
that affected the protein sequence and were not supported by the human
genome sequence, EST sequences, or the HapMap polymorphism database,
reflecting errors in the RefSeq entries. The two available chimpanzee genome
assemblies, ARACHNE and PCAP [3], were screened for the presence of
chimpanzee orthologs of human protease genes, by using the curated set of
human protease cDNA sequences and a combination of BLAT and BLAST
algorithms [57,58]. After in silico searches, the predicted chimpanzee cDNA
and protein sequences were extracted and compared to the human orthologs.
All sequences and alignments were manually inspected to identify putative
frameshifts or incomplete sequences due to gaps in the assemblies.
Significantly divergent proteases were defined as those showing a percentage
of identity at the protein level below 2 standard deviations of the mean
(96.88%). The Ka/Ks ratio was calculated for the full-length protein using the
program K-Estimator [59].
Identification of chimpanzee-specific proteases was carried out by three
approaches: (a) screening of the chimpanzee genome with protease amino acid
sequences using the TBLASTN algorithm, (b) analysis of chimpanzee regions
syntenic to human pseudogenes that are active in other species, and (c) specific
comparison of clusters of protease genes for the presence or absence of
proteolytic genes.
DNA samples, PCR amplification, and DNA sequencing
Chimpanzee genomic DNA was obtained from WES cells and from
chimpanzees from different geographical regions (a gift from Dr. J.
Bertranpetit, CRG-UPF, Barcelona, Spain), human DNA from a healthy male
individual, mouse (C57BL/6J) DNA from animals from our inbred colonies,
and dog DNA from MDCK cells. Chimpanzee BAC clones CH251-545K10,
CH251-350O2, CH251-252K11, CH251-541E6, CH251-696F3, RP43-59F8,
and RP43-40A16 were obtained from Children’s Hospital Oakland Research
Institute (http://bacpac.chori.org). Conflictive regions, defined as those
presenting a frameshift, premature stop codon, or absence of initiation codon
in both ARACHNE and PCAP assemblies, were PCR-amplified from
chimpanzee and human genomic DNA by using specific oligonucleotides
(see Supplemental Table 2) and a GeneAmp 2400 PCR system. Nucleotidesequencing was performed in an ABI Prism 310 sequencer (Perkin–Elmer Life
Sciences).
Southern blot hybridization
Genomic DNA (10 Ag) from the indicated species or BAC DNA (3 Ag) was
digested for 16 h, and DNA fragments were separated in agarose gels and
transferred to nylon membranes. Hybridization was performed with probes
amplified from genomic DNAwith specific oligonucleotides (see Supplemental
Table 2), washed at 65-C with 0.1 SSC, 0.1% SDS for 30 min, and
autoradiographed.Acknowledgments
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